Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
- 1 January 1999
- journal article
- research article
- Published by Elsevier
- Vol. 33 (1) , 63-72
- https://doi.org/10.1016/s0272-6386(99)70259-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Iron, Anemia, and InfectionNutrition Reviews, 2009
- Epoetin in the Anaemia of Rheumatoid ArthritisClinical Immunotherapeutics, 1996
- Evidence-based recommendations for the clinical use of recombinant human erythropoietinAmerican Journal of Kidney Diseases, 1995
- Pathogenesis and Treatment of the Anemia of Chronic DiseaseThe Lancet Healthy Longevity, 1994
- Pitfalls in Quantitating HemodialysisSeminars in Dialysis, 1993
- Effect of iron complexes on adjuvant arthritis in rats.Annals of the Rheumatic Diseases, 1992
- Elevated circulating levels of interleukin-6 in patients with chronic renal failureKidney International, 1991
- Elevated Serum Levels of C-Reactive Protein in Hemodialysis PatientsNephron, 1990
- MECHANISM OF EXACERBATION OF RHEUMATOID SYNOVITIS BY TOTAL-DOSE IRON-DEXTRAN INFUSION: IN-VIVO DEMONSTRATION OF IRON-PROMOTED OXIDANT STRESSThe Lancet, 1987
- Effect of intravenous iron dextran on rheumatoid synovitis.Annals of the Rheumatic Diseases, 1985